Free Trial

Lineage (LINE) Stock Price, News & Analysis

Lineage logo
$40.85 -0.15 (-0.37%)
Closing price 04:00 PM Eastern
Extended Trading
$40.84 -0.02 (-0.04%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Lineage Stock (NASDAQ:LINE)

Key Stats

Today's Range
$40.49
$42.10
50-Day Range
$41.00
$47.89
52-Week Range
$40.55
$89.85
Volume
1.15 million shs
Average Volume
1.20 million shs
Market Capitalization
$9.34 billion
P/E Ratio
N/A
Dividend Yield
5.17%
Price Target
$61.70
Consensus Rating
Hold

Company Overview

Lineage Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

LINE MarketRank™: 

Lineage scored higher than 93% of companies evaluated by MarketBeat, and ranked 114th out of 933 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Lineage has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 7 buy ratings, 10 hold ratings, and 3 sell ratings.

  • Amount of Analyst Coverage

    Lineage has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Lineage's stock forecast and price target.
  • Earnings Growth

    Earnings for Lineage are expected to grow by 36.75% in the coming year, from $2.34 to $3.20 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Lineage is -12.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Lineage is -12.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Lineage has a PEG Ratio of 4.19. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Lineage has a P/B Ratio of 0.97. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Lineage's valuation and earnings.
  • Short Interest

    There is no current short interest data available for LINE.
  • Dividend Leadership

    Lineage is a leading dividend payer. It pays a dividend yield of 5.05%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Lineage does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Lineage will have a dividend payout ratio of 65.94% next year. This indicates that Lineage will be able to sustain or increase its dividend.

  • Read more about Lineage's dividend.
  • Short Interest

    There is no current short interest data available for LINE.
  • News Sentiment

    Lineage has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 18 news articles for Lineage this week, compared to 13 articles on an average week.
  • Search Interest

    4 people have searched for LINE on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Lineage to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Lineage insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,194,980.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    71.90% of the stock of Lineage is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Lineage's insider trading history.
Receive LINE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lineage and its competitors with MarketBeat's FREE daily newsletter.

LINE Stock News Headlines

Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway
Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!
Analysts Set Lineage, Inc. (NASDAQ:LINE) Target Price at $61.70
See More Headlines

LINE Stock Analysis - Frequently Asked Questions

Lineage's stock was trading at $58.57 on January 1st, 2025. Since then, LINE stock has decreased by 30.2% and is now trading at $40.9060.

Lineage, Inc. (NASDAQ:LINE) released its quarterly earnings data on Wednesday, April, 30th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.82 by $0.04. The business's quarterly revenue was down 2.7% compared to the same quarter last year.
Read the conference call transcript
.

Lineage (LINE) raised $4.4 billion in an initial public offering (IPO) on Thursday, July 25th 2024. The company issued 56,882,051 shares at $78.00 per share.

Lineage's top institutional shareholders include Public Employees Retirement System of Ohio (0.01%), Perkins Coie Trust Co (0.01%), Sumitomo Mitsui DS Asset Management Company Ltd (0.01%) and IFM Investors Pty Ltd (0.01%). Insiders that own company stock include Adam Matthew Schwartz Forste, Kevin Patrick Marchetti, Robert Crisci, Jeffrey Alvarez Rivera, Sudarsan V Thattai and Abigail S Fleming.
View institutional ownership trends
.

Shares of LINE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lineage investors own include Amgen (AMGN), AstraZeneca (AZN), Confluent (CFLT), Halozyme Therapeutics (HALO), Trimble (TRMB), Arch Capital Group (ACGL) and Adobe (ADBE).

Company Calendar

Record date for 4/21 Dividend
3/31/2025
Ex-Dividend for 4/21 Dividend
3/31/2025
Dividend Payable
4/21/2025
Last Earnings
4/30/2025
Record date for 7/21 Dividend
6/30/2025
Ex-Dividend for 7/21 Dividend
6/30/2025
Today
7/16/2025
Dividend Payable
7/21/2025
Next Earnings (Confirmed)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
REIT - EQTY TRUST - OTHER
Sub-Industry
Trading
Current Symbol
NASDAQ:LINE
Previous Symbol
NASDAQ:LINE
CIK
1868159
Web
N/A
Fax
N/A
Employees
26,000
Year Founded
N/A

Price Target and Rating

High Price Target
$94.00
Low Price Target
$42.00
Potential Upside/Downside
+50.8%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
21 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
17.48
P/E Growth
4.19
Net Income
-$686 million
Net Margins
-11.88%
Pretax Margin
-14.59%
Return on Equity
-7.24%
Return on Assets
-3.34%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
0.99
Quick Ratio
0.86

Sales & Book Value

Annual Sales
$5.34 billion
Price / Sales
1.75
Cash Flow
$0.99 per share
Price / Cash Flow
41.23
Book Value
$42.33 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
228,590,000
Free Float
64,234,000
Market Cap
$9.35 billion
Optionable
Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:LINE) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners